Uromitexan Stungulyf, lausn 100 mg/ml Իսլանդիա - իսլանդերեն - LYFJASTOFNUN (Icelandic Medicines Agency)

uromitexan stungulyf, lausn 100 mg/ml

baxter medical ab* - mesnum inn - stungulyf, lausn - 100 mg/ml

Sendoxan Stungulyfsstofn, lausn 1 g Իսլանդիա - իսլանդերեն - LYFJASTOFNUN (Icelandic Medicines Agency)

sendoxan stungulyfsstofn, lausn 1 g

baxter medical ab* - cyclophosphamidum inn - stungulyfsstofn, lausn - 1 g

Sendoxan Stungulyfsstofn, lausn 500 mg Իսլանդիա - իսլանդերեն - LYFJASTOFNUN (Icelandic Medicines Agency)

sendoxan stungulyfsstofn, lausn 500 mg

baxter medical ab* - cyclophosphamidum inn - stungulyfsstofn, lausn - 500 mg

Holoxan Innrennslisstofn, lausn 500 mg Իսլանդիա - իսլանդերեն - LYFJASTOFNUN (Icelandic Medicines Agency)

holoxan innrennslisstofn, lausn 500 mg

baxter medical ab* - ifosfamidum inn - innrennslisstofn, lausn - 500 mg

Holoxan Innrennslisstofn, lausn 2000 mg Իսլանդիա - իսլանդերեն - LYFJASTOFNUN (Icelandic Medicines Agency)

holoxan innrennslisstofn, lausn 2000 mg

baxter medical ab* - ifosfamidum inn - innrennslisstofn, lausn - 2000 mg

Holoxan Innrennslisstofn, lausn 1000 mg Իսլանդիա - իսլանդերեն - LYFJASTOFNUN (Icelandic Medicines Agency)

holoxan innrennslisstofn, lausn 1000 mg

baxter medical ab* - ifosfamidum inn - innrennslisstofn, lausn - 1000 mg

Sendoxan Tafla 50 mg Իսլանդիա - իսլանդերեն - LYFJASTOFNUN (Icelandic Medicines Agency)

sendoxan tafla 50 mg

baxter medical ab* - cyclophosphamidum inn - tafla - 50 mg

Toradol Stungulyf, lausn 30 mg/ml Իսլանդիա - իսլանդերեն - LYFJASTOFNUN (Icelandic Medicines Agency)

toradol stungulyf, lausn 30 mg/ml

atnahs pharma netherlands b.v. - ketorolacum trómetamól - stungulyf, lausn - 30 mg/ml

Flunixin (Flunixin Solutions for Injection) Stungulyf, lausn 50 mg/ml Իսլանդիա - իսլանդերեն - LYFJASTOFNUN (Icelandic Medicines Agency)

flunixin (flunixin solutions for injection) stungulyf, lausn 50 mg/ml

norbrook laboratories (ireland) limited - flunixinum meglúmínsalt - stungulyf, lausn - 50 mg/ml

Trodelvy Եվրոպական Միություն - իսլանդերեն - EMA (European Medicines Agency)

trodelvy

gilead sciences ireland uc - sacituzumab govitecan - breast neoplasms; triple negative breast neoplasms - Æxlishemjandi lyf - trodelvy as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic triple-negative breast cancer (mtnbc) who have received two or more prior systemic therapies, including at least one of them for advanced disease.